NCT05215743View on ClinicalTrials.gov

Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

November 22, 2022

Study Completion Date

December 22, 2022

Conditions
Acute Myocardial InfarctionIschemia-reperfusion InjuryReperfusion Injury, MyocardialReperfusion ArrhythmiasReperfusion Injury
Interventions
DRUG

Antioxidant therapy

Active therapy

DRUG

NaCl 0.9%

Placebo

Trial Locations (1)

Unknown

University of Chile, Santiago

All Listed Sponsors
collaborator

Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

OTHER_GOV

lead

University of Chile

OTHER